Showing results (101-110 of 237) with videos related to
Sort By:
Pageof 24
Cancer Science|April 14, 2010
Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expressionRintaro Noro, Akihiko Miyanaga, Yuji Minegishi, et al.BMC Pulmonary Medicine|December 19, 2024
Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediatorsShunichi Nishima, Takeru Kashiwada, Yoshinobu Saito, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 7, 2024
A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung CancerSatoru Matsuki, Namiko Taniuchi, Naoko Okada, et al.JTO Clinical and Research Reports|October 27, 2023
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLCYuto Terashima, Masaru Matsumoto, Hiroki Iida, et al.Molecular Cancer Therapeutics|November 22, 2013
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cellsKazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al.BMJ Open Respiratory Research|May 16, 2025
Optimal dose of maintenance steroid therapy for relapse of chronic eosinophilic pneumonia: a multicentre retrospective studyKenichiro Atsumi, Shunichi Nishima, Toru Tanaka, et al.BMC Cancer|April 18, 2015
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancerMasaru Matsumoto, Masahiro Seike, Rintaro Noro, et al.International Journal of Oncology|January 20, 2016
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cellsNobuhiko Nishijima, Masahiro Seike, Chie Soeno, et al.Medicine|September 10, 2022
Black pleural effusion caused by a pancreaticopleural fistula associated with autoimmune pancreatitis: A case reportKeiki Miyadera, Kakeru Hisakane, Yuki Kato, et al.Gene|January 9, 2023
Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancerKakeru Hisakane, Masahiro Seike, Teppei Sugano, et al.Pageof 24